Literature DB >> 220279

Production of diglyceride from phosphatidylinositol in activated human platelets.

S Rittenhouse-Simmons.   

Abstract

Human platelets generate diglyceride within 5 s of exposure to thrombin. Production of diglyceride is transient. 15 s after the addition of thrombin, the levels of diglyceride have increased up to 30-fold, but decrease thereafter. Prior incubation of platelets with 2 mM dibutyryl cyclic AMP prevents both the generation of diglyceride and the secretion of serotonin. Acetylsalicylic acid (100 microgram/ml), which completely inhibits prostaglandin endoperoxide synthesis, does not block diglyceride production and serotonin secretion induced by thrombin. Based on studies examining the incorporation of [3H]arachidonic acid into diglyceride of prelabeled platelets exposed to thrombin, it is concluded that neither phosphatidic acid nor triglyceride is the source of the diglyceride. Phosphatidylinositol appears to be the most likely source, both because its loss of radiolabel is sizable and rapid enough to account for the appearance of radiolabel in diglyceride, and because a phosphatidylinositol-specific phosphodiesterase, described in this report, exists in platelets. The phosphatidylinositol-phosphodiesterase, which produces diglyceride and inositol phosphate, requires Ca+2 and shows optimal activity at pH 7. The enzyme does not act upon phosphatidylcholine, phosphatidylethanolamine, or phosphatidylserine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220279      PMCID: PMC371991          DOI: 10.1172/JCI109339

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Metabolism of phospholipids. V. Studies of phosphatidic acid phosphatase.

Authors:  R COLEMAN; G HUEBSCHER
Journal:  Biochim Biophys Acta       Date:  1962-01-29

3.  The enzymatic synthesis of inositol monophosphatide.

Authors:  H PAULUS; E P KENNEDY
Journal:  J Biol Chem       Date:  1960-05       Impact factor: 5.157

4.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

5.  Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane.

Authors:  H J Chap; R F Zwaal; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1977-06-02

Review 6.  Metabolism of phosphatidate at the plasma membrane.

Authors:  D Allan; R H Michell
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

7.  Mobilization of arachidonic acid in human platelets. Kinetics and Ca2+ dependency.

Authors:  S Rittenhouse-Simmons; F A Russell; D Deykin
Journal:  Biochim Biophys Acta       Date:  1977-09-28

8.  The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.

Authors:  S Rittenhouse-Simmons; D Deykin
Journal:  Biochim Biophys Acta       Date:  1978-11-01

9.  Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2.

Authors:  O V Miller; R A Johnson; R R Gorman
Journal:  Prostaglandins       Date:  1977-04

10.  Calcium ion-dependent diacylglycerol accumulation in erythrocytes is associated with microvesiculation but not with efflux of potassium ions.

Authors:  D Allan; R H Michell
Journal:  Biochem J       Date:  1977-09-15       Impact factor: 3.857

View more
  104 in total

1.  A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets.

Authors:  D L Nunn; S P Watson
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

2.  Characterization of partially purified phospholipase C from human platelet membranes.

Authors:  Y Banno; Y Nozawa
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle
Journal:  Biochem J       Date:  1987-05-15       Impact factor: 3.857

4.  Characterization of phosphoinositide-specific phospholipase C from human platelets.

Authors:  V Manne; H F Kung
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism.

Authors:  L H Block; M Knorr; E Vogt; R Locher; W Vetter; P Groscurth; B Y Qiao; D Pometta; R James; M Regenass
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Activation of phospholipase C associated with isolated rabbit platelet membranes by guanosine 5'-[gamma-thio]triphosphate and by thrombin in the presence of GTP.

Authors:  J K Hrbolich; M Culty; R J Haslam
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

7.  (-)-Adrenaline-induced, calcium-dependent phosphorylation of proteins in human platelets.

Authors:  L H Block; H Jaksche; P Erne; P Bolli; F R Bühler
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.

Authors:  L L Friesen; J M Gerrard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

9.  The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells.

Authors:  A R Whorton; C E Willis; R S Kent; S L Young
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

10.  Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.

Authors:  J M Gerrard; S E Kindom; D A Peterson; J G White
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.